We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » VAXGEN WINS HHS CONTRACT FOR ANTHRAX VACCINE
VAXGEN WINS HHS CONTRACT FOR ANTHRAX VACCINE
November 12, 2004
HHS has awarded an $877.5 million contract to VaxGen to develop, test and manufacture enough new anthrax vaccine to inoculate millions of Americans in the event of a bioterrorist attack using inhalation anthrax.